Introduction
Fungal infections range from superficial skin conditions to life-threatening systemic diseases. Antifungal medicines play a vital role in managing infections caused by Candida, Aspergillus, Cryptococcus, Mucorales, dermatophytes, and other fungi.
At Nirvana Pharma, we distribute a broad spectrum of antifungal agents including Polyenes, Azoles, Echinocandins, Allylamines, Pyrimidine analogues, and Topical agents, ensuring access to safe and certified formulations for hospitals, pharmacies, and clinics.
📋 Antifungal Product Catalogue
Polyenes
| Drug Name |
Classification |
Common Strengths (Dosage Forms) |
Primary Uses |
| Amphotericin B (Conventional) |
Polyene |
IV: 50 mg vial (powder) |
Systemic mycoses (Aspergillosis, Mucormycosis, Cryptococcosis) |
| Liposomal Amphotericin B |
Polyene |
IV: 50 mg vial (liposomal) |
Invasive fungal infections, better tolerated |
| Nystatin |
Polyene |
Oral suspension: 100,000 units/mL; Cream/ointment: 100,000 units/g |
Oral & cutaneous Candidiasis |
Azoles – Imidazoles
| Drug Name |
Classification |
Common Strengths (Dosage Forms) |
Primary Uses |
| Ketoconazole |
Imidazole (Azole) |
Tab: 200 mg; Cream/shampoo: 2% |
Systemic & topical mycoses (mainly topical now) |
| Clotrimazole |
Imidazole (Azole) |
Cream: 1%; Vaginal tab: 100, 200, 500 mg |
Vulvovaginal candidiasis, tinea infections |
| Miconazole |
Imidazole (Azole) |
Cream: 2%; Oral gel: 20 mg/g |
Oral thrush, skin fungal infections |
| Econazole |
Imidazole (Azole) |
Cream: 1% |
Dermatophytosis, candidiasis |
Azoles – Triazoles
| Drug Name |
Classification |
Common Strengths (Dosage Forms) |
Primary Uses |
| Fluconazole |
Triazole |
Tab: 50, 100, 150, 200 mg; IV: 200 mg/100 mL; Suspension: 10 mg/mL, 40 mg/mL |
Candidiasis, Cryptococcosis |
| Itraconazole |
Triazole |
Cap: 100 mg; Oral soln: 10 mg/mL |
Aspergillosis, Histoplasmosis, Onychomycosis |
| Voriconazole |
Triazole |
Tab: 50, 200 mg; IV: 200 mg vial; Suspension: 40 mg/mL |
Invasive Aspergillosis, Fusariosis |
| Posaconazole |
Triazole |
Tab: 100 mg (DR); Suspension: 40 mg/mL; IV: 300 mg/16.7 mL |
Prophylaxis of invasive fungal infections |
| Isavuconazole (Isavuconazonium sulfate) |
Triazole |
Cap: 186 mg; IV: 372 mg vial |
Invasive Aspergillosis, Mucormycosis |
Echinocandins
| Drug Name |
Classification |
Common Strengths (Dosage Forms) |
Primary Uses |
| Caspofungin |
Echinocandin |
IV: 50 mg, 70 mg vials |
Invasive Candidiasis, Aspergillosis |
| Micafungin |
Echinocandin |
IV: 50 mg, 100 mg vials |
Candida infections, Aspergillosis |
| Anidulafungin |
Echinocandin |
IV: 100 mg vials |
Candidemia, Invasive Candidiasis |
Allylamines
| Drug Name |
Classification |
Common Strengths (Dosage Forms) |
Primary Uses |
| Terbinafine |
Allylamine |
Tab: 250 mg; Cream/gel/spray: 1% |
Dermatophyte infections, Onychomycosis |
| Naftifine |
Allylamine |
Topical cream/gel: 1% |
Tinea infections |
Others
| Drug Name |
Classification |
Common Strengths (Dosage Forms) |
Primary Uses |
| Flucytosine (5-FC) |
Pyrimidine analogue |
Cap: 250, 500 mg; IV: 2.5 g/250 mL |
Cryptococcal meningitis (with Amphotericin B) |
| Ciclopirox |
Hydroxypyridone |
Cream/lotion: 1%; Nail lacquer: 8% |
Onychomycosis, dermal fungal infections |
| Tolnaftate |
Thiocarbamate |
Cream/powder: 1% |
Athlete’s foot, ringworm, dermatophytosis |
Closing Note
At Nirvana Pharma, we provide comprehensive antifungal solutions covering systemic and superficial infections. Our antifungal catalogue supports hospitals, pharmacies, and clinics with certified, authentic, and timely supply of critical formulations.
